RiboX Therapeutics Ltd.
RiboX Therapeutics Ltd.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias | Cytopenia, Disease Attributes, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Recurrence, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Not yet recruiting | Phase 1 | 2026-09-23 | NCT07765966 | |
| Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 | Stomatognathic Diseases, Xerostomia, mouth disorder, salivary gland disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-23 | NCT06714253 | |
| Exploration of Circular RNA in B-cell Hematologic Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-08-19 | NCT07774572 | |
| Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, autoimmune disease, immune system disorder | Recruiting | Early phase 1 | 2026-01-23 | NCT07322718 |